Seeking Alpha

Merck & Co. Inc. (MRK)

()

News & PR
Market Currents

Buzz
Twitter: MRK

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

2010 Investing: A Tale of Two Economies

Dec 28 • Philip Davis • 44 Comments
European Shares at 15-Month High

Dec 28 • The LFB • Comment!
Outlook for a Merry Christmas Eve

Dec 24 • Philip Davis • 37 Comments
Wall Street Breakfast: Must-Know News

Dec 23 • Suzanne Miller • 14 Comments
VTV: Buying Value for 2010

Dec 22 • Invest With An Edge • Comment!
Components of the Dow Jones High Yield Select 10 Index

Dec 21 • David Hunkar • 5 Comments
Large Caps Are Breaking Out: Is This a Trend?

Dec 14 • TraderMark • 4 Comments
China Biotech Week in Review: Deals and CRO News

Dec 14 • ChinaBio Today • 1 Comment
Merck Starts China Trial of Cancer Vaccine

Dec 14 • ChinaBio Today • 1 Comment
Eli Lilly Plans Innovation Strategy to Counter Generics Threat

Dec 13 • The Burrill Report • 2 Comments
Dogs Remain Dogs in 2009

Dec 13 • Bespoke Investment Group • 10 Comments
Thursday Options Recap

Dec 10 • Frederic Ruffy • Comment!
28 U.S. Dividend Stocks from the DJ STOXX Global Select Dividend 100 Index

Dec 10 • David Hunkar • 10 Comments
The Principles of Dividend Investing

Dec 7 • Chuck Carnevale • 6 Comments
Sonic Foundry: To Believe or Not to Believe (in the Mediasite Franchise)?

Dec 7 • Jeffrey Walkenhorst • Comment!
Buying Bonds with Coupons that Grow

Dec 7 • Fred Fraenkel • 4 Comments
Global Pharmaceutical Industry Boosted by Rising Drug Approvals and Sales in Q3

Dec 7 • Research Recap • Comment!
14 Stocks and 2 Strategies for High Yield Dividends

Dec 7 • Scott's Investments • 7 Comments
Astra-Zeneca Flies to 'Jupiter' on Drug Results

Dec 6 • Larry Meyers • 6 Comments
H1N1: What It Means for Pharma

Dec 2 • R. Scott Raynovich • 2 Comments
Dan Loeb: Investment Outlook 'Favorable' Through Mid-2010

Dec 2 • Market Folly • 3 Comments
Health Care Takes Bigger Slice of Risk Capital

Nov 30 • Sydney Williams • Comment!
China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO

Nov 30 • ChinaBio Today • 2 Comments
13 Biotechs to Watch for at Hematology Conference

Nov 30 • Michael Becker • Comment!
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Merck Triumphs in Defense of Osteoporosis Drug...for Now

Nov 26 • The Burrill Report • Comment!
Wall Street Breakfast: Must-Know News

Nov 25 • Suzanne Miller • 12 Comments
Merck Serono to Spend $225 Million on New Beijing R&D Center

Nov 25 • ChinaBio Today • 1 Comment
Value Investors Know Insmed's Cash Wealth Offers No Margin of Safety

Nov 24 • Saj Karsan • 8 Comments
Vitamin Beats Statin: Is Merck's Zetia in Trouble?

Nov 20 • The Burrill Report • 10 Comments
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates

Nov 20 • R. Saito • 3 Comments
Will Questions over Cholestorol Drug Zetia Create a Major Setback for Merck?

Nov 17 • Zacks.com • Comment!
U.S. Industrials Staging a Comeback

Nov 16 • Market Blog • 1 Comment
Will the M&A Wave Push Financial ETFs Higher?

Nov 16 • Eric Dutram • Comment!
Direction of Cholesterol Debate Could Benefit Abbott Labs

Nov 16 • EP Vantage • 1 Comment
Cholesterol Drug Trials: A Victory for Abbott Means a Loss for Merck

Nov 16 • Derek Lowe • Comment!
Wall Street Breakfast: Must-Know News

Nov 16 • Suzanne Miller • 35 Comments
Dogs of the Dow: How Do They Look Today?

Nov 15 • Larry Bellehumeur • 3 Comments
D.C. Vaccine Conference: Why Investors Should Stay Tuned

Nov 9 • M. E. Garza • Comment!
19 High Yield Stocks that Historically Outperform

Nov 9 • Scott's Investments • 4 Comments
10 Dividend Stocks for Enterprising Investors

Nov 6 • Benjamin Clark • 28 Comments

Merck & Co. Inc. (MRK)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers